ACTU – actuate therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Actuate Therapeutics, Inc. (ACTU) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Actuate Therapeutics (NASDAQ:ACTU) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Actuate Therapeutics Phase 2 Metastatic Pancreatic Cancer Data Selected for Oral and Poster Presentation at ASCO GI 2026 [Yahoo! Finance]
Actuate Therapeutics Phase 2 Metastatic Pancreatic Cancer Data Selected for Oral and Poster Presentation at ASCO GI 2026
Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma
Form SCHEDULE 13G ACTUATE THERAPEUTICS, Filed by: Voss Capital, LP
Form 144 ACTUATE THERAPEUTICS, Filed by: Kairos Venture Partners II, L.P.
Form 8-K ACTUATE THERAPEUTICS, For: Nov 28
Form 424B5 ACTUATE THERAPEUTICS,
Form 8-K ACTUATE THERAPEUTICS, For: Nov 21
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.